Purpose: To investigate the pulmonary outcomes of early extubation (within the first 24 hours of life) with synchronized nasal intermittent positive pressure ventilation (NIPPV) in extremely premature infants born at 25-26 weeks' gestation. Methods: Medical records of extremely premature infants (gestational age: 25-26 weeks) born and admitted to the Keimyung University Dongsan Medical Center between January 2015 and December 2015 (n=42) were reviewed retrospectively. The early extubation group included infants who were extubated within the first 24 hours of life and was compared with a control group that included infants who remained ventilated beyond the first 24 hours of life. Extubation failure was defined as the need for reintubation within 72 hours after extubation. Results: Of the 35 enrolled infants, 22 (62.9%) were extubated within the first 24 hours of life. No significant differences in perinatal factors were observed between the early extubation and control groups. Between the two groups, the incidence rates of extubation failure (18.2% [4/22] 
INTRODUCTION
Surfactant replacement and invasive mechanical ventilation are used to treat respiratory distress syndrome (RDS) in premature infants. Although surfactant replacement in premature infants decreased the incidence of bronchopulmonary dysplasia (BPD) 1) , persistent invasive mechanical ventilation after surfactant replacement is the major risk factor of BPD 2) . Early surfactant administration followed by extubation involving nasal continuous positive airway pressure (NCPAP) or nasal intermittent positive pressure ventilation (NIPPV) has been shown to decrease the incidence of BPD in very low birth weight infants (VLBWI) in observational studies 3, 4) , and minimized the need for mechanical ventilation via endotracheal tube in the first week of life 5, 6) .
NIPPV is a noninvasive mode of ventilation that uses a nasal interface that augments the infant's spontaneous breath efforts by providing a backup rate 7, 8) . It is effective in premature infants who require respiratory support, as it reduces the incidence of premature apnea and atelectasis, and improves ventilationperfusion matching while decreasing extubation failures [9] [10] [11] [12] [13] .
The incidence of BPD was also reduced in infants managed by NIPPV [14] [15] [16] . In comparison with NCPAP, NIPPV reduced the need for endotracheal ventilation in premature infants with early extubation after receiving early surfactant for RDS 6, 17) .
Synchronized NIPPV can improve chest wall stability and pulmonary mechanics by decreasing thoracoabdominal motion asynchrony 18) , increasing flow delivery by increasing the peak inspiratory pressure (PIP) to higher than the positive endexpiratory pressure (PEEP) 9) , increasing tidal and minute volumes 19) , and decreasing work of breathing 20) .
Although some studies from Korea investigated the therapeutic effect of NIPPV or CPAP in premature infants 21, 22) , studies on extremely premature infants are limited. In this study, we aimed to investigate the pulmonary outcomes of early airway extubation (within the first 24 hours of life) with synchronized NIPPV in extremely premature infants born at 25-26 weeks' gestation.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of 42 ex- [9] [10] [11] 13) . Caffeine citrate (Neocaf ® , loading dose, 20 mg/kg) was intravenously administrated before extubation. The decision to extubate within the within the first 24 hours of life or to continue with mechanical ventilation was at the attending neonatologist's discretion.
After airway extubation, nasal respiratory support was provided via a nasal prong by using the Medijet NCPAP System (MedinMedical Innovations GmbH, Puchheim, Germany), which was set in the synchronized NIPPV mode. During synchronized NIPPV, PIP was started at 10-15 cmH2O, PEEP was set at 6-9 cmH2O, inspiratory time was set at 0.6s, and the backup or mandatory rate was set between 20 and 30 breaths per minute. The
FiO2 was adjusted to maintain SpO2 at 88-95%.
The early extubation group, which included infants extubated within the first 24 hours of life, was compared with the control group, which included infants who remained ventilated beyond the first 24 hours of life. Extubation failure was defined as the need for reintubation within 72 hours after extubation.
The criteria were as follows: respiratory acidosis (PaCO2 >65 mmHg of two consecutive blood gases); FiO2 >0.4 to maintain SpO2 at 88-95%; and apnea episodes that required bag/mask ventilation 24) .
The following variables were analyzed for the perinatal factors: 
RESULTS
Of the 35 infants, 22 (62.9%) were extubated within the first 24 hours after birth. The mean time to airway extubation was 18.8±3.4 hours in the early extubation group and 40.5±27.7 hours in the control group.
The comparison of the perinatal factors between the early extubation and control groups is shown in Table 1 . No significant differences in GA, BW, delivery mode, sex, multiple gestation, antenatal steroid use, PIH, PPROM, oligohydramnios, and Apgar score at 5 min were observed between the two groups.
The outcomes after airway extubation are shown in Table   2 . The incidence of extubation failure in the early extubation group (18.2%, 4/22) was higher than that in the control group (13.3%, 2/15), but the difference was not statistically significant were reported to range from 5% to 15% in VLBWI 6, [9] [10] [11] .
Ramanathan et al. 6) reported that 17% of infants born at 26-29 weeks' gestation needed endotracheal ventilation at 7 days of age in the NIPPV group. Because of lower gestational age in the present study, it might be associated with the higher rates in the need for endotracheal ventilation at 7 days of age.
Fluctuating cerebral blood flow (CBF) is associated with the development of IVH 29, 30) . High PCO2 levels have been associated with the development of IVH, which contributes to the fluctuating CBF 31, 32) . However, in a recent multicenter study 33) , permissive hypercapnia did not increase the risk of IVH. In the present study, we targeted the maintenance of capillary PCO2 levels ≤65 mmHg. The incidence of IVH grade ≥3 in the early
DISCUSSION
The rate of early extubation (within the first 24 hours of life) using synchronized NIPPV was 59.5%, and the rate of successful early extubation without extubation failure was 81.8%. Our data support the application of early extubation (within the first 24
hours of life) with synchronized NIPPV, which indicate a success rate that exceeds the previously reported rates 27, 28) . Al Faleh et al.
reported that the rate of early extubation (in the first 48 hours of life) with CPAP in extremely low birth weight infants (ELBWI) was 32% and that the rate of successful extubation was 80% 28) . In other previous trials, the rates of extubation failure with NIPPV 34) .
Invasive mechanical ventilation is a major risk factor of BPD 2) .
The time on endotracheal ventilation in this present study was relatively shorter compared to those reported in previous studies 6, 12) . According to the latest nationwide survey 35) , the combined rates of BPD or death were 68.7% at 25 weeks GA and 58.9% at 26 weeks GA. In the present study, the combined rate of clinical BPD or death was about 40%. The duration of invasive ventilator use was a significant risk factor of ROP according to a latest nationwide survey 36) . The incidence of ROP requiring treatment in the early extubation group was higher than that in the control group, but relatively lower than that in the latest nationwide survey 36) . However, no clear benefit was demonstrated for the use of synchronized NIPPV in terms of lowering the incidence rates of BPD or ROP. Further evidence of efficacy is needed.
Pneumoperitoneum as a complication of barotrauma is a rare condition resulting from mechanical ventilation 37) . It is interesting that pneumoperitoneum without bowel perforation developed in two infants who were receiving synchronized NIPPV. In a previous study, gastric perforation developed in neonates who were receiving NIPPV 38) . However, intestinal perforation was not associated with NIPPV use in the other studies [9] [10] [11] [12] [13] 16) . Further studies are needed to clarify whether pneu moperitoneum is a complication of nasal respiratory support.
Massive pulmonary hemorrhage within the first 5 days of life is a major cause of early death in ELBWI 39, 40) . In this study, massive pulmonary hemorrhage developed in two infants who were receiving synchronized NIPPV, which led to their deaths.
However, no clear evidence shows that nasal respiratory support increases the risk of fatal massive pulmonary hemorrhage.
In conclusion, early extubation (within the first 24 hours of life) with synchronized NIPPV is safe and effective in the extremely premature infants born at 25-26 weeks' gestation, and does not indicate increased risks of extubation failure and other morbidities. The lack of a comparative investigation of episodes of apnea or bradycardia between the two groups is a limitation of this study. Further prospective studies, preferably largerscale randomized controlled trials that incorporate NIPPV and NCPAP comparisons, are needed to assess the effectiveness of synchronized NIPPV in extremely premature infants.
